Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
Mayo Clinic
Debiopharm International SA
Essen Biotech
Eisai Inc.
AbbVie
University of Kentucky
Asan Medical Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center